/SLNX

SLNX Stock - Solanbridge Group, Inc.

Q: What is the analyst price target for SLNX?

Analyst price target information is not currently available for SLNX.

Q: What is SLNX's market cap?

Market capitalization information is not currently available for SLNX.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SLNX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.15

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-60	$-16.5	$-6,620	$-6,740	$-7,260
Net Income	$-67.75	$-34.661	$-6,636	$-6,746	$-7,325
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$0.00	$0.00	$0.00	$0.00	$-0.00

Company Overview

Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.

Visit Website

Frequently Asked Questions about SLNX

What is SLNX's current stock price?

Solanbridge Group, Inc. (SLNX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for SLNX?

No analyst price targets are currently available for this stock.

What sector is Solanbridge Group, Inc. in?

Solanbridge Group, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is SLNX's market cap?

Solanbridge Group, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does SLNX pay dividends?

No, Solanbridge Group, Inc. does not currently pay a dividend to shareholders.